Dr Farah adds:“The potential benefits flowing from the InVue™ cannot be over-estimated. Diagnostic pathology is such a critical component in the surgical treatment of cancer, and for so long it has been disconnected from this process. InVue™ brings pathology and surgery together in the operating theatre to enhance the capabilities of both, and ultimately facilitate faster and more accurate patient care.”
Another positive development from Optiscan with it`s own digital diagnostic surgical offering.
This should allow the breast cancer study to progress at Royal Melbourne Hospital.
https://thewest.com.au/business/bulls-n-bears/optiscan-on-cusp-of-real-time-cancer-imaging-breakthrough-c-11951222
Add the recently announced Robotic development collaboration with Mayo and the $3m funding for development of miniaturized application for Gastro
and the future looks bright especially in light of the proven quality of Optiscan`s technology.
Dr Farah adds:“The potential benefits flowing from the InVue™...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.015(6.82%) |
Mkt cap ! $196.3M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 24.5¢ | 23.0¢ | $277.1K | 1.171M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 61499 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 150000 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| OIL (ASX) Chart |